ARS Pharmaceuticals is a fast-growing, innovative company dedicated to transforming the treatment of severe allergic reactions with neffy®, the first and only FDA-approved needle-free epinephrine product. If you’re motivated to make a meaningful impact, this is your opportunity to join a collaborative, entrepreneurial, and inclusive culture.
JOB SUMMARY:
The Financial Reporting Manager is responsible for the preparation of all external financial reporting and related SEC filings, accounting for equity-based transactions, and a broad range of accounting operation activities to ensure compliance with GAAP, regulations, and corporate policies. This position will report to the Financial Reporting & SOX Manager. ARS Pharmaceuticals, Inc., operates in a hybrid work environment.
ESSENTIAL DUTIES & RESPONSIBILITIES:
- Coordinate and prepare SEC filings (using Active Disclosure), including Form 10-Q’s, Form 10-K’s, Form 8-K’s, and press releases in compliance with GAAP and SEC regulations.
- Support quarterly reviews and annual audits including providing supporting documentation and following up on questions as needed.
- Participate in the monthly financial close process ensuring accounts assigned are properly recorded, prepare account reconciliations, journal entries, and report preparation.
- Assist in the oversight of financial policies, procedures, controls, and reporting systems including SOX 404 compliance and the management of external SOX consultants.
- Participate in finance and accounting projects including system and process implementations as assigned.
- Assist with support preparation for external tax preparers.
- Perform other duties as assigned.
EDUCATION AND EXPERIENCE:
- Bachelor’s Degree or higher in Accounting/Finance (or equivalent) is required
- Certified Public Accountant (CPA) is required.
- Minimum of 3+ years of in‑house accounting experience at a public company and/or public accounting experience is required.
- Biotech/pharma or high-tech industry experience is preferred.
KNOWLEDGE, SKILLS, AND ABILITIES:
- Strong knowledge of US GAAP and Sarbanes-Oxley Section 404.
- Advanced Excel skills.
- Active Disclosure experience is preferred.
- Equity compensation accounting experience preferred.
- Experience with large-scale enterprise software systems preferred.
- Ability to handle multiple tasks and shift with changing priorities.
- Highly organized and accountable for meeting tight deadlines.
- Excellent verbal and written communication skills are required.
- Ability to collaborate effectively in a fast-paced, cross-functional environment.
- Capability to learn new tasks in appropriate timeframes.
This position is also eligible for Equity, 401k matching, and our excellent benefits package including 100% employer paid Medical, Dental & Vision for employees. View the full package here: ARS Careers Page
ARS Pharmaceuticals believes in Equal Opportunity for all and is committed to ensuring all individuals, including individuals with disabilities, have an opportunity to apply for those positions that they are interested in and qualify for without regard to race, religion, color, national origin, citizenship, sex, sexual orientation, gender identity, age, veteran status, disability, genetic information, or any other protected characteristic. ARS Pharmaceuticals is also committed to providing reasonable accommodation to qualified individuals so that an individual can perform their job-related duties. If you are interested in applying for an employment opportunity and require special assistance or an accommodation to apply due to a disability, please contact us at [email protected]
The position will be posted until a final candidate is selected for the requisition or the requisition has a sufficient number of applications.
Similar Jobs
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering
